Acquisitions in India completed

The earlier announced acquisitions of Medicover Healthcare Private Limited “Medicover Fertility India” and the 22% shareholding of Sahrudaya Healthcare Private Limited “MaxCure”, both located in India, are now completed. The transactions were cash settled for € 18.5 million.

From 1 October 2017, Medicover Fertility’s results and financial position will be consolidated and the holding in Maxcure will be accounted for as an associated company.

For further information, please contact:

Paula Treutiger, Corporate Communications & Investor Relations, Director           

Phone: +46-73-66 6599 Mail: paula.treutiger@medicover.com

This information is information that Medicover AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 10.30 CET on 4 October, 2017.

Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities and laboratories and the largest markets are Poland and Germany. In 2016, Medicover had revenues around €0.5 billion and 14,400 employees. For more information, go to www.medicover.com

Tags:

About Us

Medicover is a leading international healthcare and diagnostic services provider in Poland, Germany, Romania, Ukraine and certain other markets, primarily in Central and Eastern Europe (“CEE”). Additionally, Medicover is in the process of entering the fast-growing Indian healthcare market in order to expand its geographical footprint and further leverage its emerging markets capabilities. Medicover offers a broad range of healthcare services and a significant hub-and-spoke diagnostic laboratory network, supported by extensively developed proprietary software and information systems infrastructure. Medicover operates through two divisions: Healthcare Services and Diagnostic Services.

Subscribe